Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)-Reference-Cited by-同舟云学术

Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)

Published:2018-03-19 Issue:3 Volume:19 Page:911
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Del Campo José,Gallego-Durán Rocío,Gallego Paloma,Grande Lourdes

Funder

Instituto de Salud Carlos III

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/19/3/911/pdf

Reference74 articles.

1. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease;Ludwig;Mayo Clin. Proc.,1980

2. AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions;Dig. Liver Dis.,2017

3. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

4. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

5. HCC-NAFLD Italian Study Group. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study;Piscaglia;Hepatology,2016

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic dysfunction-associated steatotic liver disease and its link to cancer;Metabolism;2024-11

2. m6A epitranscriptomic and epigenetic crosstalk in liver fibrosis: Special emphasis on DNA methylation and non-coding RNAs;Cellular Signalling;2024-10

3. Noncoding RNA-Mediated Epigenetic Regulation in Hepatic Stellate Cells of Liver Fibrosis;Non-Coding RNA;2024-08-07

4. Comprehensive pharmacological and experimental study of Ginsenoside Re as a potential therapeutic agent for non-alcoholic fatty liver disease;Biomedicine & Pharmacotherapy;2024-08

5. An examination of global research trends for exploring the associations between the gut microbiota and nonalcoholic fatty liver disease through bibliometric and visualization analysis;Gut Pathogens;2024-07-03